• Selumetinib (SEMEDX) produced by BigBearPharma has been approved in Laos

  Vientiane, Laos - April 8, 2024 - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer thera···【Read More】

  Update: 04 Jun,2026Source: BigbearViews: 75

• BigBear Pharma Announces Approval of Baricitinib (BARUDX) in Laos

  Vientiane, Laos - April 8, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative c···【Read More】

  Update: 03 Jun,2026Source: BigbearViews: 81

• Laos Big Bear Pharma: A New Force in Generic Drugs Rising from the Heart of Southeast Asia

  On the banks of the Mekong River in Laos, a transformation in healthcare accessibility is quietly taking place. As the Lao government continues to inc···【Read More】

  Update: 02 Jun,2026Source: BigbearViews: 87

• BigBear Pharma Announces Approval of Larotrectinib (LARODX) in Laos

  Vientiane, Laos - May 30, 2024 - BIGBEARPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer therap···【Read More】

  Update: 02 Jun,2026Source: BigbearViews: 86

• BigBear Pharma Announces Approval of Adagrasib (ADADX) in Laos

  Vientiane, Laos – July 14, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative c···【Read More】

  Update: 01 Jun,2026Source: BigbearViews: 91

• Tazemetostat (TAZEDX) manufactured by Big Bear Pharmaceutical has been approved in Laos

  Vientiane, Laos, August 01, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer tre···【Read More】

  Update: 27 May,2026Source: BigbearViews: 103

• BigBear Pharma announces that Olaparib (OLADX) has been approved in Laos

  September 20, 2024 - Vientiane, Laos - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer···【Read More】

  Update: 26 May,2026Source: BigbearViews: 110

• BigBearPharma announces that Letermovir (LETEDX) has been approved in Laos

  September 20, 2024 - Vientiane, Laos - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative therapi···【Read More】

  Update: 26 May,2026Source: BigbearViews: 196

• BigBear Pharma Announces Approval of Pralsetinib (PRASEDX) in Laos

  Vientiane, Laos, August 12, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer tre···【Read More】

  Update: 22 May,2026Source: BigbearViews: 111

• Lusutrombopag manufactured by BigBear Pharmaceuticals approved in Laos

  Vientiane, Laos – October 08, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovativ···【Read More】

  Update: 21 May,2026Source: BigbearViews: 118

• BigBear Pharma Announces Approval of Encorafenib (BRATODX) in Laos

  Vientiane, Laos – October 12, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovativ···【Read More】

  Update: 19 May,2026Source: BigbearViews: 106

• BigBear Pharma: Binimetinib (MEKTODX) Receives Approval from the Lao Ministry of Health

  Vientiane, Laos—October 12, 2024—BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treat···【Read More】

  Update: 14 May,2026Source: BigbearViews: 113

• BigBear Pharma: Selpercatinib (SEPADX) approved for marketing by the Lao Ministry of Health

  Vientiane, Laos - November 20, 2023 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer ···【Read More】

  Update: 12 May,2026Source: BigbearViews: 114